Hot Pursuit     25-Jan-16
Strong Q3 numbers boost Unichem Lab
Unichem Laboratories surged 4.8% to Rs 239.10 at 10:31 IST on BSE after net profit spurted 897.1% to Rs 20.54 crore on 15.6% growth in net sales to Rs 303.93 crore in Q3 December 2015 over Q3 December 2014.
The result was announced on Saturday, 23 January 2016.

Meanwhile, the S&P BSE Sensex was up 162.42 points or 0.66% at 24,598.08.

On BSE, so far 60,000 shares were traded in the counter as against average daily volume of 22,278 shares in the past one quarter. The stock hit a high of Rs 245.90 and a low of Rs 238 so far during the day. The stock had hit a record high of Rs 334 on 6 October 2015. The stock had hit a 52-week low of Rs 174 on 8 June 2015. The stock had underperformed the market over the past one month till 22 January 2016, sliding 14.15% compared with Sensex's 4.51% fall. The scrip had also underperformed the market in past one quarter, declining 20.52% as against Sensex's 10.45% fall.

The small-cap company has equity capital of Rs 18.16 crore. Face value per share is Rs 2.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives. The company has strong skills in product development, process chemistry and manufacturing of complex APIs as well as dosage forms.

Previous News
  Unichem Laboratories reports consolidated net loss of Rs 70.67 crore in the September 2022 quarter
 ( Results - Announcements 11-Nov-22   14:55 )
  Unichem Laboratories reports consolidated net loss of Rs 63.93 crore in the December 2022 quarter
 ( Results - Announcements 06-Feb-23   16:14 )
  Unichem Laboratories to discuss results
 ( Corporate News - 16-May-23   12:12 )
  Unichem Laboratories schedules board meeting
 ( Corporate News - 10-May-24   11:53 )
  Sun Pharmaceuticals Industries Ltd Falls 1.71%
 ( Hot Pursuit - 20-Jun-24   09:30 )
  Unichem Laboratories standalone net profit rises 341.78% in the March 2019 quarter
 ( Results - Announcements 25-May-19   15:12 )
  Unichem Laboratories schedules board meeting
 ( Corporate News - 01-Aug-22   15:58 )
  Unichem Laboratories receives USFDA approval for Bystolic® (nebivolol) Tablets
 ( Corporate News - 16-Mar-22   10:09 )
  Unichem Labs jumps on USFDA approval for hypertension drug
 ( Hot Pursuit - 25-Nov-19   10:31 )
  Unichem Laboratories receives USFDA approval for Zonisamide Capsules
 ( Corporate News - 27-Jan-21   14:50 )
  Unichem Laboratories to convene board meeting
 ( Corporate News - 23-Oct-20   14:04 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top